Camber Capital Management’s GSK GSK Stock Holding History

Camber Capital Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Hold	0	–	–	–	27
2025 Q1	–	Sell	-2,500,000	Closed	-$84.6M	–	30
2024 Q4	$84.6M	Sell	2,500,000 -500,000	-17%	-$16.9M	1.96%	13
2024 Q3	$123M	Buy	3,000,000 +325,000	+12%	+$13.3M	3.9%	8
2024 Q2	$103M	Buy	2,675,000 +500,000	+23%	+$19.3M	2.85%	12
2024 Q1	$93.2M	Hold	2,175,000	–	–	2.29%	14
2023 Q4	$80.6M	Sell	2,175,000 -675,000	-24%	-$25M	2.05%	13
2023 Q3	$103M	Sell	2,850,000 -1,250,000	-30%	-$45.3M	3.41%	11
2023 Q2	$146M	Sell	4,100,000 -500,000	-11%	-$17.8M	4.76%	8
2023 Q1	$164M	Buy	4,600,000 +850,000	+23%	+$30.2M	5.03%	6
2022 Q4	$132M	Buy	3,750,000 +1,250,000	+50%	+$43.9M	4.52%	8
2022 Q3	$73.6M	Buy	+2,500,000	New	+$73.6M	2.25%	15
2022 Q2	–	Sell	-800,000	Closed	-$43.6M	–	42
2022 Q1	$43.6M	Sell	800,000 -1,200,000	-60%	-$65.3M	1.58%	22
2021 Q4	$110M	Sell	2,000,000 -200,000	-9%	-$11M	3.79%	8
2021 Q3	$105M	Hold	2,200,000	–	–	3.24%	10
2021 Q2	$110M	Buy	2,200,000 +200,000	+10%	+$9.96M	3.69%	10
2021 Q1	$89.2M	Sell	2,000,000 -800,000	-29%	-$35.7M	3.06%	11
2020 Q4	$129M	Buy	2,800,000 +2,440,000	+678%	+$112M	4.52%	8
2020 Q3	$16.9M	Sell	360,000 -2,040,000	-85%	-$96M	0.89%	28
2020 Q2	$122M	Hold	2,400,000	–	–	7%	6
2020 Q1	$114M	Buy	+2,400,000	New	+$114M	6.79%	4
2019 Q4	–	Sell	-400,000	Closed	-$21.3M	–	32
2019 Q3	$21.3M	Hold	400,000	–	–	1.12%	26
2019 Q2	$20M	Buy	+400,000	New	+$20M	0.93%	23
2019 Q1	–	Sell	-1,600,000	Closed	-$76.4M	–	31
2018 Q4	$76.4M	Buy	+1,600,000	New	+$76.4M	3.63%	9
2018 Q2	–	Sell	-1,200,000	Closed	-$58.6M	–	33
2018 Q1	$58.6M	Hold	1,200,000	–	–	2.88%	15
2017 Q4	$53.2M	Buy	+1,200,000	New	+$53.2M	2.6%	12
2015 Q1	–	Sell	-1,400,000	Closed	-$74.8M	–	38
2014 Q4	$74.8M	Buy	1,400,000 +440,000	+46%	+$23.5M	4.97%	3
2014 Q3	$55.2M	Buy	+960,000	New	+$55.2M	5.18%	5